Harmony Biosciences
Commercializes WAKIX for narcolepsy while developing next-generation pitolisant and rare-neurology therapies.
$39.21
After-hours close−0.01 (−0.03%)
At close$39.22(−1.63%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $1.11 | — | — |
| Aug 2026 | $0.96 | $1.28 | +33.9% |
| May 2026 | $0.76 | $0.55 | −27.6% |
| Feb 2026 | $0.84 | $0.38 | −54.8% |
| Nov 2025 | $0.92 | $0.87 | −5.4% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | $1.11 | — | — | $274.5M | — | — |
| Aug 4, 2026 | $0.96 | $1.28 | +33.9% | $250.8M | $261.3M | +4.2% |
| May 7, 2026 | $0.76 | $0.55 | −27.6% | $220.8M | $215.4M | −2.5% |
| Feb 24, 2026 | $0.84 | $0.38 | −54.8% | $240.3M | $243.8M | +1.4% |
| Nov 4, 2025 | $0.92 | $0.87 | −5.4% | $240.0M | $239.5M | −0.2% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 25, 2025 | ||||||
| Oct 29, 2024 | ||||||
| Aug 6, 2024 | ||||||
| Apr 30, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Oct 31, 2023 | ||||||
| Aug 1, 2023 | ||||||
| May 2, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Nov 1, 2022 | ||||||
| Aug 2, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 20, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||